BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 21, Issue 39
  • This Article
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (16355)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-4) series.
Item 
Count 
PDF1227
WORD355
HTML9295
Figures (1-2)474
Tables (1-4)622
 Sum=11973
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse1342
Download3040
 Sum=4382
Oct 21, 2015 (publication date) through Oct 30, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Systematic Reviews
Copyright ©The Author(s) 2015.
World J Gastroenterol. Oct 21, 2015; 21(39): 11185-11198
Published online Oct 21, 2015. doi: 10.3748/wjg.v21.i39.11185
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 Flow chart of the electronic literature search strategy using MEDLINE, Scopus, EMBASE and other sources. Examples of PubMed Equations: recurrent hepatocellular carcinoma[Title/Abstract] OR recurrent hepatocellular carcinoma[MeSH Terms] OR hepatocellular carcinoma recurrence[Title/Abstract] AND liver transplantation[MeSH Terms] OR liver transplantation[Title/Abstract] OR liver transplant[Title/Abstract] OR liver transplant[MeSH Terms] AND treatment[Title/Abstract] OR therapy[Title/Abstract] OR management[Title/Abstract] OR recurrent hepatocellular carcinoma[Title/Abstract] OR recurrent hepatocellular carcinoma[MeSH Terms] OR hepatocellular carcinoma recurrence[Title/Abstract] AND liver transplantation[MeSH Terms] OR liver transplantation[Title/Abstract] OR liver transplant[Title/Abstract] OR liver transplant[MeSH Terms] AND sorafenib[Title/Abstract] OR sorafenib[MeSH Terms] OR Nexavar[Title/Abstract]) OR Nexavar[MeSH Terms]).
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 Increasing number of publication on the management of recurrent hepatocellular carcinoma in liver transplantation patients.
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345